netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Liraglutide found 10 matches
Open monograph to display formulary status BNF Category
  Liraglutide  (Saxenda®) Central nervous system - Anti-obesity drugs acting on the gastro-intestinal tract - 04.05.01
  Liraglutide  (Victoza®) Endocrine system - GLP1 agonists - 06.01.02.03
  Liraglutide   (Saxenda) Endocrine system - GLP1 agonists - 06.01.02.03
  Xultophy® Insulin degludec and Liraglutide Endocrine system - Long Acting Insulin Analogues - 06.01.01.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section LSCMMG: Insulin degludec plus liraglutide (06.01.01.02)
link in drug section MHRA: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products (06.01.02.03)
link in drug section MHRA: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products (06.01.02.03)
link in drug section MHRA: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products (04.05.01)
link in drug section NICE TA664: Liraglutide for managing overweight and obesity (04.05.01)
link in drug section NICE TA664: Liraglutide for managing overweight and obesity (06.01.02.03)


 
netFormulary